William A. Curran

Davis Polk is advising Tyson Foods, Inc. on its $2.16 billion acquisition of the Keystone Foods business from Marfrig Global Foods. The transaction, which is expected to close in mid-fiscal…

Davis Polk advised Pernix Therapeutics Holdings, Inc. in connection with separate private exchange offers for its existing 12% senior secured notes due 2020 held by certain holders for new…

Davis Polk advised the representatives of the several underwriters in connection with the $60 million initial public offering of common stock of Constellation Pharmaceuticals, Inc. The…

Davis Polk is advising SUEZ S.A. on its $601 million sale of 20% of SUEZ Water Resources Inc. to PGGM. The transaction is expected to be completed by the first half of 2019, subject to…

Davis Polk advised Auris Medical Holding AG on a public offering of common shares and warrants. The common shares are listed on the NASDAQ Global Market under the symbol “EARS.” Auris…

Davis Polk is advising affiliates of Goldman Sachs in connection with their acquisition of Boyd Corporation from affiliates of Genstar Capital. Financial terms of the transaction were not…

Davis Polk advised the administrative agent and worked with a steering committee of lenders under a $1.2 billion prepetition secured credit facility in the chapter 11 restructuring of HGIM…

Davis Polk advised the global coordinators and bookrunners in connection with the public offering by PagSeguro Digital Ltd. and Universo Online S.A., as selling shareholder, of an aggregate…

Davis Polk advised the underwriters in connection with an initial public offering of 7,359,998 shares of common stock of Aptinyx Inc., at $16.00 per share (which includes the exercise in…

Davis Polk advised the joint book-running managers in connection with an offering by The Bank of N.T. Butterfield & Son Limited of $75 million aggregate principal amount of its 5…